Bingluo Zhou

443 total citations
11 papers, 293 citations indexed

About

Bingluo Zhou is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Bingluo Zhou has authored 11 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in Bingluo Zhou's work include Autophagy in Disease and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Bingluo Zhou is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA modifications and cancer (2 papers). Bingluo Zhou collaborates with scholars based in China. Bingluo Zhou's co-authors include Hongchuan Jin, Xian Wang, Lifeng Feng, Wenxia Xu, Liyuan Zhu, Qiyin Zhou, Shilong Ying, Yiran Zhu, Xinyang Hu and Jianwei Zhou and has published in prestigious journals such as European Journal of Medicinal Chemistry, Cell Death and Disease and Theranostics.

In The Last Decade

Bingluo Zhou

11 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bingluo Zhou China	9	207	106	70	45	28	11	293
Shufeng Ji China	11	172 0.8×	125 1.2×	79 1.1×	58 1.3×	35 1.3×	17	301
Kanako Inaba Japan	10	170 0.8×	83 0.8×	77 1.1×	90 2.0×	32 1.1×	13	306
Yingxia Ning China	10	212 1.0×	147 1.4×	109 1.6×	23 0.5×	49 1.8×	20	354
Jing Cui China	13	213 1.0×	152 1.4×	88 1.3×	30 0.7×	28 1.0×	19	328
Melissa A. Yao United States	6	132 0.6×	69 0.7×	71 1.0×	79 1.8×	46 1.6×	8	273
Enrico Moiso United States	6	144 0.7×	53 0.5×	60 0.9×	78 1.7×	27 1.0×	13	263
Er‐Bin Zhang China	8	188 0.9×	114 1.1×	53 0.8×	26 0.6×	26 0.9×	8	282
Haojiang Dai China	7	207 1.0×	74 0.7×	72 1.0×	43 1.0×	12 0.4×	9	315

Countries citing papers authored by Bingluo Zhou

Since Specialization

Citations

This map shows the geographic impact of Bingluo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingluo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingluo Zhou more than expected).

Fields of papers citing papers by Bingluo Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingluo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingluo Zhou. The network helps show where Bingluo Zhou may publish in the future.

Co-authorship network of co-authors of Bingluo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Bingluo Zhou. A scholar is included among the top collaborators of Bingluo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingluo Zhou. Bingluo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Yu, Lei, Bingluo Zhou, Ling Li, et al.. (2023). HSF1 promotes CD69⁺ Treg differentiation to inhibit colitis progression. Theranostics. 13(6). 1892–1905. 12 indexed citations

Zhu, Yiran, Bingluo Zhou, Xinyang Hu, et al.. (2022). LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c‐Myc mRNA stability. Clinical and Translational Medicine. 12(1). e703–e703. 87 indexed citations

Feng, Lifeng, Miaoqin Chen, Yiling Li, et al.. (2021). Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis. Cell Death and Disease. 12(4). 405–405. 39 indexed citations

Zhou, Bingluo, Yiran Zhu, Wenxia Xu, et al.. (2021). Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B. Frontiers in Cell and Developmental Biology. 9. 741736–741736. 12 indexed citations

Zhu, Heping, Shilong Ying, Bingluo Zhou, et al.. (2021). Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 593–604. 7 indexed citations

Zhu, Heping, Shilong Ying, Bingluo Zhou, et al.. (2020). Discovery of novel 2-aryl-3-sulfonamido-pyridines (HoAns) as microtubule polymerization inhibitors with potent antitumor activities. European Journal of Medicinal Chemistry. 211. 113117–113117. 8 indexed citations

Dai, Dongjun, Bingluo Zhou, Wenxia Xu, Hongchuan Jin, & Xian Wang. (2019). CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process. Journal of Cancer. 10(4). 949–956. 10 indexed citations

Dai, Dongjun, Bingluo Zhou, Yiming Zhong, Hongchuan Jin, & Xian Wang. (2019). Survival of patients with resected primary colorectal mucinous adenocarcinoma: A competing risk nomogram analysis. Oncology Letters. 18(6). 6594–6604. 12 indexed citations

Xu, Wenxia, Wei Qi, Mengjiao Han, et al.. (2018). CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer. International Journal of Biological Sciences. 14(9). 1054–1066. 45 indexed citations

10.

Xu, Wenxia, Bingluo Zhou, Xiaoya Zhao, et al.. (2018). KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance. International Journal of Biological Sciences. 14(9). 1122–1132. 46 indexed citations

11.

Xu, Wenxia, Qiqi Shi, Xiaoling Qian, et al.. (2018). Rab5a suppresses autophagy to promote drug resistance in cancer cells.. PubMed. 10(4). 1229–1236. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shufeng Ji Breakdown of academic impact, for papers by Kanako Inaba Breakdown of academic impact, for papers by Yingxia Ning Breakdown of academic impact, for papers by Jing Cui Breakdown of academic impact, for papers by Melissa A. Yao Breakdown of academic impact, for papers by Enrico Moiso Breakdown of academic impact, for papers by Er‐Bin Zhang Breakdown of academic impact, for papers by Haojiang Dai